基本信息
views: 0
Career Trajectory
Bio
Dr. Lundstrom established “Alphavirus-based Expression of Receptors and Ion Channels at the Glaxo Institute for Molecular Biology in Geneva, Switzerland, then expanded the utilization of Alphavirus Expression Systems to Neuroscience and Gene Therapy at Roche in Basel. He was appointed Scientific Coordinator of a Structural Genomics Network using Bacterial, Yeast, and Alphavirus Vectors for Large-scale Production of Receptors. Currently, Dr. Lundstrom focuses on Alphavirus-based Gene Therapy and Vaccine Development including COVID-19 vaccines. Dr. Lundstrom has published more than 250 scientific articles and several books.
Research Interests
Papers共 289 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
SARS-CoV-2 Variants and Global Population Vulnerabilitypp.285-316, (2024)
biorxiv(2024)
Future Science OAno. 1 (2024)
Cancersno. 11 (2024): 2030-2030
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2024)
AUTOIMMUNITY REVIEWSno. 3 (2024): 103508-103508
COMPUTERS IN BIOLOGY AND MEDICINE (2024)
Debaleena Nawn,Sk. Sarif Hassan,Elrashdy M. Redwan, Tanishta Bhattacharya,Pallab Basu,Kenneth Lundstrom,Vladimir N. Uversky
Load More
Author Statistics
#Papers: 289
#Citation: 8230
H-Index: 49
G-Index: 83
Sociability: 7
Diversity: 0
Activity: 4
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn